Amano Enzyme
天野酶(Amano Enzyme)创立于 1899 年,数代人始终专注推进酶技术:现为特种酶的全球领导者、日本最大的酶制剂制造商;同时坚持经典(非转基因)与现代生物技术并举,致力更幸福、更健康的世界。
简介
Amano Enzyme Inc. is a Japan-based specialty enzyme manufacturer and seller, making enzyme agents for pharmaceutical, food, and manufacturing industries plus diagnostic reagents, and also producing pharmaceuticals, veterinary medicines, and feed additives. Core technology centers on microbial enzyme discovery and production using strain screening (20,000+ strain library), classical mutagenesis/GMO/protein engineering, and fermentation/koji processes (including koji and liquid fermentation), plus extraction/purification and fermentation controls. Founded in 1899 (began enzyme manufacturing in 1948) and established 26 Aug 1948 for Amano Enzyme Inc.. Headquarters: Nagoya City, Aichi, Japan (2-7-1 Nishiki, Naka-ku, 460-8630). It is privately held (no stock listing shown in provided sources); ownership investors/funding: not disclosed in the provided results. Scale: 390 million yen capital and 480 employees. Key facilities include three Japanese plants (Nagoya plant, Yoro plant, Shiga plant) and an Innovation Center in Gifu. Latest 2025–2026 developments from provided materials: Sustainability Report 2025 covers FY2022–FY2025 highlights (biogas recovery growth and a Yoro sludge-to-fertilizer initiative; plus factory automation/AI/IoT for quality control). Corporate deck is dated June 2026, indicating the company is active as of then. Recent patent activity includes several applications with first filing dates in 2025–2026 (e.g., 2025 enzyme-related WO applications; 2026 US application on modified transglutaminase). Key partners/customers: not specified in the provided results.
Sources#
- Company Overview-Amano Enzyme Inc.
- AMANO Sustainability Report 2025
- Amano Enzyme Group Corporate Presentation
- About Amano Enzyme-Amano Enzyme Inc.
- Amano Enzyme 2026 Company Profile: Valuation, Funding & Investors | PitchBook
- Company Overview-Amano Enzyme Inc.
- Company History-Amano Enzyme Inc.
- Global Specialty Enzyme Production Company - Amano Enzyme
供应的生物解决方案 0
尚未被列为已评级方案的供应商。
已核实的产品关联: Edoxaban → I02; Dextranase → I02;
产品与服务
生产与研发基地 9
- Tokyo Office (Tokyo, Japan)
- Innovation Center (Kakamigahara City, Gifu, Japan)
- Nagoya Plant (Kitanagoya City, Aichi, Japan)
- Yoro Plant (Ogaki City, Gifu, Japan)
- Shiga Plant (Konan City, Shiga, Japan)
- Amano Enzyme U.S.A. Co., Ltd. (USA)
- Amano Enzyme Europe Ltd. (UK)
- Amano Enzyme Manufacturing (China), Ltd. (China)
- Amano Enzyme Asia Pacific Co., Ltd. (Thailand)
来自公司网站及自动化调研的生产、研发等基地;不含街道地址。
子公司: Amano Enzyme U.S.A. Co., Ltd. · Amano Enzyme Europe Ltd. · Amano Enzyme Manufacturing (China), Ltd. · Amano Enzyme Asia Pacific Co., Ltd. · Amano Commercial Fim Co., Ltd. (Affiliated)
商业模式 · enzymes
Amano Enzyme Inc. manufactures and sells enzyme agents for the pharmaceutical, food, and manufacturing industries, as well as diagnostic reagents, pharmaceuticals, veterinary medicines, and feed additives. The company serves a global customer base, with over 70% of its sales generated from overseas markets. It earns revenue by leveraging its expertise in biotechnology and traditional fermentation to provide high-quality, specialized enzyme products tailored to customer needs.
Overseas sales account for over 70% of the company's total sales. “As the world continues to globalize, overseas sales make up over 70% of our sales, with this number growing each year.” | www.amano-enzyme.com weak (company, news, market research, other) |
The company was founded in 1899 and began manufacturing enzymes in 1948. “Founded in 1899, Amano Enzyme began manufacturing enzymes in 1948 and has since been supplying them to markets around the world for over 70 years.” | www.amano-enzyme.com weak (company, news, market research, other) |
The company maintains an extensive strain library containing over 20,000 microorganisms. “Amano has an extensive strain library (over 20,000 microorganisms obtained from a variety of environments such as deep sea) Innovation center and production technology center continue working on the discovery of new …” | www.amano-enzyme.com weak (company, news, market research, other) |
| Enzymes for Edoxaban intermediate synthesis Enzymatic methods for producing Edoxaban intermediates replace traditional chemical synthesis, reducing organic solvents by 90%, raw material costs by 50%, and filtration times from 7 to 3. “Edoxaban, an oral anticoagulant, is conventionally produced by chemical methods, but it has recently been reported that a portion of the intermediate synthesis can be replaced by enzymatic methods, thereby reducing …” | www.amano-enzyme.com weak (company, news, market research, other) |
| YL-T, Nuclease, and Deamizyme T Amano's enzyme solutions for yeast extract production enable a one-step, one-vessel process that cuts production time by 27%. “Amano Enzyme enables yeast extract manufacturers to create high-quality yeast extracts with increased yields of IMP and GMP while shortening production time by 27%.” | lp.amano-enzyme.com weak (company, news, market research, other) |
| Dextranase L Amano Dextranase L Amano replaces the use of anti-biotic agents for controlling dextran during sugar processing and reduces energy consumption and waste. “Through our experience in Japan, only Dextranase is used controlling MK value during the process (no anti-biotic agents at all).” | slideum.com weak (company, news, market research, other) |
| Thermostable microbial β-amylase Thermostable microbial β-amylase replaces barley or wheat-derived enzymes in maltose syrup production, offering higher reaction temperatures and better suitability for starch liquefaction. “The microbial enzyme was demonstrated to be superior to the barley- or wheat-derived enzymes, which are currently used in the production of maltose syrup.” | www.amano-enzyme.com weak (company, news, market research, other) |
状态
近期新闻 5
由自动检索获得;摘要为机器生成的英文。标题含公司名称,或摘要以该公司为主体——引用前请核对原文。
- 2026-09-28 BRIN dan Amano Enzyme Jepang Perkuat Riset Teknologi Enzim - DentingId denting.idAmano Enzyme Inc. Jepang bekerja sama dengan BRIN untuk memperkuat riset dan inovasi teknologi enzim, melalui kolaborasi internasional yang bertujuan menemukan enzim baru dan mengembangkan teknologi yang bisa diterapkan di pangan, kesehatan, bioenergi, dan sektor industri …
- 2026-06-29 New technology addresses plant-based formulation challenges | Food Business News foodbusinessnews.netAmano Enzyme Inc. unveiled ProBoost Neutra, an enzyme technology claimed to enhance the flavor and functionality of plant-based foods and improve pea protein solubility and emulsification, with potential use in ready-to-drink beverages and powder supplements and compatibility …
- 2026-06-15 Amano Enzyme unveils new pea‑protein technology - Food and Drink Technology foodanddrinktechnology.comAmano Enzyme has unveiled ProBoost Neutra, a next‑generation enzyme that improves solubility, emulsification, and flavor of pea protein isolate while enabling cleaner, milder, non‑GM, organic‑compliant processing without significant capital expenditure. The technology aims to …
- 2026-05-28 Japanese Enzyme Specialists Visit VU Life Sciences Center gmc.vu.ltAmano Enzyme, a leading Japanese company in enzyme research, production, and application, visited Vilnius University Life Sciences Center to discuss potential collaborations in protein design, manufacturing, and biotechnological applications. The meeting, attended by senior Amano …
- 2026-05-25 Two alumni take part in JICA-AMANO Academic Bridge Program at Nagoya University | News & Events | Nagoya University en.nagoya-u.ac.jpAmano Enzyme Inc. funded and supported the JICA-AMANO Academic Bridge program, and its Innovation Center in Gifu Prefecture hosted discussions with two Nagoya University alumni who presented research and visited the company.
关系网络:股东、合作伙伴、同类
股权与投资方 5
| 子公司 | Amano Enzyme U.S.A. Co., Ltd |
| 子公司 | Amano Enzyme Europe Ltd |
| 子公司 | Amano Enzyme Manufacturing |
| 子公司 | Amano Enzyme Asia Pacific Co., Ltd |
| 子公司 | Amano Commercial Fim Co., Ltd |
同类企业
SHANDONG LONCT ENZYMES CO.,LTD · S.I. Biozyme · Qingdao Vland Biotech Group Co., Ltd. · Mianyang Habio Bioengineering Co., Ltd · KDN Biotech (SHANGHAI) CO., LTD · Leveking Biotech · XIKE Enzymes · Vland Enzymes
公司信息
注册编号
- Corporate Number (Japan): 7180001034007
来自自动化调研(公司网站、公告、商业企业数据库),未经人工核对。注册编号请以官方登记为准。
身份与联系方式
联系方式、人员和法律信息仅向会员开放。
会员登录